Cardiovascular Systems Investor Relations Material
Latest events
Q1 2023
Cardiovascular Systems
Access the full event backlog
Slides, Transcripts, and Reports from 12,000+ public companies
Latest reports from Cardiovascular Systems Inc
Access all reports
Cardiovascular Systems, Inc. develops and commercializes solutions to treat peripheral and coronary artery diseases in the United States and internationally. The company offers peripheral artery disease products to treat various plaque types in above and below the knee, including calcified plaque; and peripheral support products under the Diamondback 360 brand name.
Latest articles
Quartr Brings Stories Behind the Numbers to Light
Quartr simplifies access to IR material and puts qualitative insights and company narratives front and center.
3 Feb 2025
The Evolution of the IRO Role: Staying Informed and Strategic With Quartr Pro
Staying informed is critical for IROs. Quartr Pro simplifies gathering market insights and narrative positioning with unprecedented speed and precision.
3 Feb 2025
Mips: The Gore-Tex of Brain Protection
How Mips turned a critical safety flaw into a global success, redefining helmet protection with its technology and ingredient brand business model.
24 Jan 2025
Ticker symbol
CSII
Country
πΊπΈ United States